A Randomised, Double-blind, Three-period Crossover Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With Type 1 Diabetes
Phase of Trial: Phase I
Latest Information Update: 14 Dec 2017
At a glance
- Drugs Glucagon (Primary)
- Indications Hypoglycaemia
- Focus Adverse reactions; First in man
- Sponsors Adocia
- 11 Dec 2017 Status changed from recruiting to completed.
- 20 Nov 2017 According to an Adocia media release, detailed results of this clinical trial are intended to be submitted for publication at a major diabetes conference.
- 20 Nov 2017 Results presented in an Adocia Media Release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History